567 POSTER Efficacy of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in combination with cytotoxic agents

Flavio Solca, Anke Baum, Frank Himmelsbach, A. Amelsberg, G. R. Adolf

European Journal of Cancer Supplements · 2006 · 19 citations · 0 references

Concepts